1.Effects of genistein on the matrix metalloproteinase inhibitor 1 mRNA levels of HSC-T6 cell in vitro
Yun WANG ; Junwang XU ; Lei FU
Journal of Xi'an Jiaotong University(Medical Sciences) 1981;0(03):-
Objective By using estradiol(E2) as positive control to observe the effects of genistein(GST) on the matrix metalloproteinase inhibitor 1 mRNA levels of HSC-T6 cell in vitro.Methods HSC-T6 cells were exposed to different concentrations of E2 0.1?mol/L and GST 0.5-50?mol/L for 36 hours.The TIMP-1 mRNA levels were measured by the quantitative reverse-transcription polymerase chain reaction(RT-PCR).Results The TIMP-1 mRNA levels of HSC-T6 cells at different concentrations of E2 and GST were lower than those of the normal control(P
2.Effects of recombinant human relaxin-2 on hepatic stellate cell proliferation, synthesis of Collagen Ⅰ,and mRNA expressions of TGF-β1 and CTGF in vitro
Zhen CHEN ; Junwang XU ; Su YAN ; Ke CHEN ; Xiude FAN
Journal of Xi'an Jiaotong University(Medical Sciences) 2017;38(1):44-47,57
ABSTRACT:Objective To validate that relaxin can resist hepatic fibrosis at the cellular level and explore its molecular mechanism in order to provide experimental basis for the treatment of liver cirrhosis.Methods Cultured HSC-T6s were treated with different concentrations (20,50 and 100 ng/mL)of recombinant human relaxin-2 (RLX-2).The proliferation of HSC-T6 was measured by MTT colorimetric assay.The content of type Ⅰcollagen in the cell culture supernatant of each group was detected by ELISA at 48 h of drug intervention;RT-PCR was used to detect the mRNA expressions of CTGF and TGF-β1 in HSC-T6 at 48 h of drug intervention.Results RLX-2 inhibited the proliferation of HSC and reduced type Ⅰ collagen content of HSC cells.It also inhibited the CTGF mRNA expression of HSC,but did not have a significant effect on the expression of TGF-β1 mRNA. Conclusion In the experiment of culturing HSC-T6 in vitro,RLX-2 may play a role in rat liver fibrosis by inhibiting cell proliferation and type Ⅰ collagen and CTGF mRNA expressions.
3.Of genes and microbes: solving the intricacies in host genomes.
Jun WANG ; Liang CHEN ; Na ZHAO ; Xizhan XU ; Yakun XU ; Baoli ZHU
Protein & Cell 2018;9(5):446-461
Microbiome research is a quickly developing field in biomedical research, and we have witnessed its potential in understanding the physiology, metabolism and immunology, its critical role in understanding the health and disease of the host, and its vast capacity in disease prediction, intervention and treatment. However, many of the fundamental questions still need to be addressed, including the shaping forces of microbial diversity between individuals and across time. Microbiome research falls into the classical nature vs. nurture scenario, such that host genetics shape part of the microbiome, while environmental influences change the original course of microbiome development. In this review, we focus on the nature, i.e., the genetic part of the equation, and summarize the recent efforts in understanding which parts of the genome, especially the human and mouse genome, play important roles in determining the composition and functions of microbial communities, primarily in the gut but also on the skin. We aim to present an overview of different approaches in studying the intricate relationships between host genetic variations and microbes, its underlying philosophy and methodology, and we aim to highlight a few key discoveries along this exploration, as well as current pitfalls. More evidence and results will surely appear in upcoming studies, and the accumulating knowledge will lead to a deeper understanding of what we could finally term a "hologenome", that is, the organized, closely interacting genome of the host and the microbiome.
Animals
;
Biomedical Research
;
Genes
;
Genetic Variation
;
Genome
;
Host-Pathogen Interactions
;
genetics
;
Humans
;
Metagenomics
;
Microbiota
4.Infection control measures and practice in gastrointestinal endoscopy departments during the novel coronavirus infection period
Xu ZHANG ; Qian ZHAO ; Xiaona KANG ; Xinlan LU ; Mudan REN ; Juan ZHANG ; Li REN ; Suhong ZHANG ; Zhiyong ZHANG ; Yan YIN ; Junwang XU ; Shuixiang HE ; Guifang LU
Journal of Xi'an Jiaotong University(Medical Sciences) 2021;42(1):128-131,151
【Objective】 To explore and evaluate infection control measures of preventing cross-contamination of novel coronavirus during gastrointestinal endoscopy treatment. 【Methods】 According to the hospital’s infection control requirements and related documents, infection control measures were formulated and implemented by combining with our actual clinical situation, including the management of the endoscope room, management and protection of patients and endoscopists. Then, we evaluated the effect of these measures. 【Results】 From January 25 to March 10, 2020, a total of 71 patients (53 males and 18 females) completed gastrointestinal endoscopy treatment, with an average age of 54 years (28-81 years). There were 36 (50.7%) cases of emergency treatment. All patients had been kept in quarantine for about 14 days (24±13), and no cross-contamination of novel coronavirus occurred. 【Conclusion】 During the novel coronavirus infection epidemic period, reasonable and effective measures should be taken to minimize the risk of infection in doctors and patients. The endoscope center should strengthen preoperative screening and management of patients, master indications of endoscopic procedures, complete endoscopists’ management and protection work, strictly follow the specifications of sterilizing gastrointestinal endoscopes, and construct the layout of "three zones and two passages".